GET THE APP
ISSN: 2155-6113
Thailand
Research Article Low-Dose Ritonavir-Boosted Atazanavir (200/100 mg) Maintained a High Virological Efficacy Up To 4 Years in Treatment-Experienced HIV-1 Infected Adults: A Prospective Cohort Study from Asia Author(s):
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 